Financing type:  best efforts prospectus offering

Gross proceeds:  $8.05-million

Offering:  20,125,000 listed shares with 10,062,500 warrants

Offering price:  40 cents per unit

Warrant exercise terms:  65 cents per listed share until Aug. 12, 2030

Overallotment option:  The agents may purchase a maximum of 2,625,000 units for overallotment purposes. As of Aug. 12, 2026, such option has been fully exercised. All information presented herein includes such exercise.

Commissions in securities:  1,074,300 agents' warrants (three agents)

Agent warrant terms:  Each agent warrant is non-transferable and is exercisable into one listed share at an exercise price of 40 cents until Aug. 12, 2028.

Disclosure:  Refer to the prospectus dated Aug. 6, 2026, and the company's news releases dated July 22, 2026, July 23, 2026, Aug. 7, 2026, and Aug. 12, 2026.